Sentinel Lymph Nodes Biopsy in Cervical Cancer

Sentinel Lymph Nodes Biopsy Versus Lymphadenectomy in Cervical Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06169787

Enrollment

Registered

2023-12-14

Start date

2023-10-14

Completion date

2024-09-30

Last updated

2024-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sentinel Lymph Node

Brief summary

This study aims to compare sentinel lymph nodes biopsy versus comprehensive lymphadenectomy in patients with early stage cervical cancer who underwent radical hysterectomy.

Interventions

PROCEDUREsentinel lymph node biopsy

sentinel lymph node biopsy

PROCEDUREcomprehensive pelvic lymphadenectomy

comprehensive pelvic lymphadenectomy

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

Women aged 20 and above with clinical FIGO stage I-IIA cervical cancer

Exclusion criteria

Women did not receive surgical treatment

Design outcomes

Primary

Measure	Time frame	Description
progression free survival	5 years	progression free survival between these two groups

Secondary

Measure	Time frame	Description
overall survival	5 years	overall survival between these two groups
Number of dissected lymph node	5 years	Number of dissected lymph node between these two groups

Other

Measure	Time frame	Description
Complications	5 years	Compication rates between the traditional and sentinel lymph node dissection groups

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026